nomegestrol acetate has been researched along with Cardiovascular Diseases in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (66.67) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Lello, S | 1 |
Basdevant, A; Conard, J; Degrelle, H; Denis, C; Guyene, TT; Ochsenbein, E; Thomas, JL | 1 |
Cefalu, WT; Greaves, KA; Thomas, MJ; Wagner, JD; Williams, JK; Zhang, L | 1 |
2 review(s) available for nomegestrol acetate and Cardiovascular Diseases
Article | Year |
---|---|
Nomegestrol acetate: pharmacology, safety profile and therapeutic efficacy.
Topics: Animals; Bone Remodeling; Breast Neoplasms; Cardiovascular Diseases; Contraceptives, Oral, Hormonal; Endometrial Hyperplasia; Female; Hormone Replacement Therapy; Humans; Megestrol; Norpregnadienes; Progesterone Congeners; Risk Assessment; Risk Factors; Thromboembolism; Treatment Outcome | 2010 |
Insulin sensitivity and cardiovascular risk factors in ovariectomized monkeys with estradiol alone or combined with nomegestrol acetate.
Topics: Administration, Oral; Animals; Aorta, Thoracic; Cardiovascular Diseases; Cholesterol; Dinoprost; Drug Combinations; Estradiol; Female; Insulin Resistance; Macaca fascicularis; Megestrol; Norpregnadienes; Ovariectomy; Risk Factors | 1998 |
1 trial(s) available for nomegestrol acetate and Cardiovascular Diseases
Article | Year |
---|---|
Cardiovascular risk factors and combined estrogen-progestin replacement therapy: a placebo-controlled study with nomegestrol acetate and estradiol.
Topics: Apoproteins; Blood Glucose; Blood Pressure; Cardiovascular Diseases; Cholesterol; Double-Blind Method; Drug Combinations; Estradiol; Estrogen Replacement Therapy; Female; Fibrinogen; Follicle Stimulating Hormone; Humans; Lipoproteins; Megestrol; Middle Aged; Norpregnadienes; Plasminogen; Progesterone Congeners; Prospective Studies; Renin; Risk Factors; Triglycerides | 1995 |